- Press releases
- Events & Presentations
- Corporate Governance
- Shareholder & Stock Info
- Analyst Coverage
- Financial Reports
- Financial calendar
- Secured Rights issue 2018
- Secured Rights issue 2017
Annual General Meeting 2020
The Annual General Meeting 2020 will take place on April 28, 2020 at 10:30 at the IVA Conference Center at Grev Turegatan 16, Stockholm.
Immunicum cherish both its shareholders’ well-being as their opportunity to the Annual General Meeting to exercise their rights as shareholders. In order to reduce the risk of spreading the virus covid-19 (the corona virus), Immuncium will hold a short and effective annual general meeting in order to limit the contacts between the participants.
As part of this, no food is served to the participants. Employees in the company who are ill or have been at risk will not be present in the premises.
Shareholders who are ill, have recently resided in a risk area or belong to a risk group should not participate, but are recommended to vote through a representative.
|Notice to AGM 2020|
Annual General Meeting 2019
|Notice to AGM 2019|
|Power of attorney form|
|Board report pursuant to rule 10.3 of the Code|
|Item 7b The Board of directors proposal regarding allocation of results|
|Item 11 Proposal regarding guidelines for remuneration|
|Item 12 Proposal amending the AoA|
|Item 13 Proposal for incentive program|
|Item 14 Proposal regarding authorization for the board of directors|
|Auditor's statement (in Swedish)|
|Terms and conditions for warrants|
Extraordinary General Meeting 2018
|Notice to EGM|
|Board resolution on directed share issue|
|Board proposal for resolution on directed share issue|
|Board resolution on rights issue|
|Board proposal for resolution on rights issue|
|Auditor’s statement (in Swedish)|
|Power of Attorney form|
|Minutes from EGM (Swedish)|
Annual General Meeting 2018
Notice of annual general meeting and additional attachments are found below.
|Notice of Annual General Meeting|
|Item 7 - The board of directors complete proposal regarding allocation of results|
|Item 11 - Guidelines for renumeration of senior management|
|Item 12 - Change of articles of association|
|Item 13 - authorization new issue|
|The board of directors' evaluation pursuant to rule 10.3 of the Code|
|The auditor's opinion under chapter 8 section 54 of the Swedish Companies Act|
|Power of attorney AGM|
In accordance with the Companies Act, is the shareholders’ influence in Immunicum exercised at the general meeting, which is the company’s highest ranking decision-making body. At the annual general meeting, the shareholders decide upon central matters, including amendments of the articles of association, confirmation of the income statements and balance sheets, possible dividends and distribution of the company’s profit or loss, election of board members and auditors and decisions regarding remuneration to the same, and decision regarding discharge of liability for the board of directors and the managing director.
In accordance with the articles of association, the notice of summons to annual general meeting shall be made by announcement in Post- och Inrikes Tidningar and by making the notice of summons available on the company’s website. Simultaneously with the notice, the company shall by way of announcement in Dagens Industri inform that notice has been made. Notice of summons to the annual general meeting and an extraordinary general meeting where a matter of amendment of the articles of association shall be resolved shall be made at earliest six (6) and not later than four (4) weeks prior the meeting. Notice of summons to other extraordinary general meetings shall be made at earliest six (6) and not later than three (3) weeks prior to the extraordinary general meeting.
Shareholders recorded in the share register in accordance with the provisions in the Companies Act, and that have given notice of their attendance to the company no later than the day mentioned in the notice, have the right to participate at the general meeting. Such day may not be on a Sunday, any other public holiday, Saturday, Midsummer Eve, Christmas Eve or New Year’s Eve and may not occur earlier than the fifth working day prior to the meeting.
At the annual general meeting, the following matters shall be addressed:
1. Election of chairman of the general meeting.
2. Preparation and approval of voting register.
3. Presentation and approval of the agenda.
4. Election of one or two persons to check the minutes.
5. Control if the meeting has been duly convened.
6. Presentation of the annual report and the audit report and, if applicable, the consolidated annual report and consolidated audit report.
a) on confirmation of the income statement and balance sheet and, if applicable, the group income statement and group balance sheet.
b) on disposition of the company’s profit or loss according to the adopted balance sheet.
c) discharge of liability for the board of directors and the managing director.
8. Determination of remuneration for the directors of the board of directors and auditors.
9. Election of directors of the board of directors and auditors and, if applicable, deputy auditors.
10. Other matters that are to be addressed at the annual general meeting pursuant to the Companies Act or the articles of association.
Extraordinary General Meeting 2017
Notice of extraordinary general meeting and additional attachments are found below.
|Meeting minutes (in Swedish)|
|Notice of extraordinary general meeting|
|Power of attorney form|
|Proposed resolution of amendment of articles of association|
|Proposed resolution - approval of rights issue|
|Board resolution - rights issue|
|13.6 - board of director's statement|
|13.6 - Auditor's statement (in Swedish)|
Annual General Meeting 2017
|Notice of summons 2017|
|Proxy Form (Swedish only)|
|Nomination Committee Statement (Swedish only)|
|The board of directors' proposal regarding authorization (Swedish only)|
|The board of directors' proposal regarding guidelines for remuneration to senior executives (Swedish only)|